No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Ziehm 3-D CT Imaging Available at Good Samaritan Medical Center – 1st Hospital in Palm Beach County to Use the Device

Editor: What To Know

  • “Our hospital is always looking for better ways to deliver high-quality care to our patients, and this new technology offers our community some of the best 3-D imaging to give our doctors an even more precise view during a surgical procedure,” said Sheri Montgomery, chief executive officer of Good Samaritan Medical Center.
  • Good Samaritan Medical Center, part of the Palm Beach Health Network, is the first hospital in Palm Beach County to use the Ziehm 3-D CT Imaging Arm for scans of the spine.
  •   “This technology allows us access to high quality, detail-rich imaging that gives patients the accuracy and efficiency you need in demanding orthopedic, neurosurgery, trauma or spinal procedures, all with minimal radiation and in less time.

February 12, 2021

Good Samaritan Medical Center, part of the Palm Beach Health Network, is the first hospital in Palm Beach County to use the Ziehm 3-D CT Imaging Arm for scans of the spine.

Ziehm 3-D CT Imaging Arm device can perform a complete scan in less than three minutes and gives more complete and thorough scans and views of the anatomy.

“Our hospital is always looking for better ways to deliver high-quality care to our patients, and this new technology offers our community some of the best 3-D imaging to give our doctors an even more precise view during a surgical procedure,” said Sheri Montgomery, chief executive officer of Good Samaritan Medical Center.  “We remain committed to providing patients in Palm Beach County with comprehensive treatment options close to home, and in a safe environment.”

This technology is all part of the growing neurosciences program at Good Samaritan Medical Center.  It is critical that you have access to the best care as quickly as possible. Good Samaritan Medical Center is here to help with recovery.

“The Ziehm 3-D CT Imaging Arm will allow us an even clearer path to better patient outcomes,” said Dr. Lloyd Zucker, Chief of Neurosurgery at Good Samaritan Medical Center.  “This technology allows us access to high quality, detail-rich imaging that gives patients the accuracy and efficiency you need in demanding orthopedic, neurosurgery, trauma or spinal procedures, all with minimal radiation and in less time.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy